Colorectal carcinoma is the most frequent type of bowel cancer and the second most common tumour disease among men and women in Germany. So-called microsatellite stable colorectal cancer with mutations in the BRAF gene represents .
*** how to diagnose rectal cancer *** Despite being diagnosed with chemotherapy-resistant colorectal cancer three years ago, Tim Givens is not only alive; he’s also in remission, thanks to a Phase I clinical trial.
The Swedish Society for Orthomolecular Medicine introduced Dr. Suzanne Humphries to lecture on the practical use of Vitamin C in Stockholm, Sweden.
What does LCH do? 78% have bone lesions, the most common area 50% have skin lesions 30% have lymph node involvement 20-50% have liver involvement • looks like primary sclerosing cholangitis & can be misdiagnosed as such • 75% need transplant -10% have Neurodegeneration -2% have lung involvement • looks like pulmonary fibrosis 20-30% have recurrences (relapse) 50-60% have the BRAF gene mutation • suspected there are additional (as yet unidentified) mutations responsible for the remainder
June 14, 2014 successful Phase III study results were shared from their melanoma trial. This comprehensive trial involved Cobimetinib and Zelboraf for treating patients with advanced cases of melanoma. All 495 patients had specific mutations of the BRAF gene and many were considered to have unresectable cases of this deadly skin cancer. The surprise came when they found these two drugs led to a longer progression free survival for patients in comparison to their treatment with Zelboraf…
NY Times covers the heartbreak that is Melanoma..and a miracle drug